Mutual of America Capital Management LLC Decreases Stake in Cabot Co. (NYSE:CBT)

Mutual of America Capital Management LLC lowered its position in Cabot Co. (NYSE:CBTFree Report) by 6.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,158 shares of the specialty chemicals company’s stock after selling 2,216 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Cabot were worth $2,852,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust raised its holdings in Cabot by 176.0% during the first quarter. Parkside Financial Bank & Trust now owns 414 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 264 shares in the last quarter. Arlington Trust Co LLC acquired a new stake in Cabot during the fourth quarter worth approximately $34,000. Milestone Investment Advisors LLC acquired a new stake in Cabot during the third quarter worth approximately $79,000. Ronald Blue Trust Inc. raised its holdings in Cabot by 460.7% during the third quarter. Ronald Blue Trust Inc. now owns 1,895 shares of the specialty chemicals company’s stock worth $127,000 after purchasing an additional 1,557 shares in the last quarter. Finally, State of Wyoming raised its holdings in Cabot by 91.2% during the second quarter. State of Wyoming now owns 2,199 shares of the specialty chemicals company’s stock worth $147,000 after purchasing an additional 1,049 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of Cabot stock opened at $90.66 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.04 and a quick ratio of 1.30. The stock has a market capitalization of $5.03 billion, a price-to-earnings ratio of 11.77, a PEG ratio of 0.98 and a beta of 1.28. The firm’s fifty day simple moving average is $88.06 and its 200-day simple moving average is $79.48. Cabot Co. has a 12 month low of $63.73 and a 12 month high of $98.34.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings data on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.07. The company had revenue of $958.00 million for the quarter, compared to analysts’ expectations of $927.28 million. Cabot had a net margin of 11.24% and a return on equity of 25.52%. As a group, equities analysts forecast that Cabot Co. will post 6.58 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. UBS Group cut shares of Cabot from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $90.00 to $87.00 in a report on Monday, January 8th. StockNews.com cut shares of Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Mizuho began coverage on shares of Cabot in a report on Wednesday, March 27th. They issued a “buy” rating and a $104.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft cut shares of Cabot from a “buy” rating to a “hold” rating and lifted their target price for the company from $88.00 to $95.00 in a report on Thursday. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $90.17.

Check Out Our Latest Stock Report on CBT

Insider Buying and Selling at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total value of $4,413,669.03. Following the transaction, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at approximately $7,767,331.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 3.07% of the stock is currently owned by corporate insiders.

Cabot Company Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Recommended Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.